Portal de investigación
Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Mirza, MR
- Lundgren, C
- Kridelka, F
- Ferrero, A
- Greggi, S
- Christensen, RD
- Soliman, PT
- Levy, T
- Sehouli, J
- Cibula, D
- Auranen, A
- Lund, B
- Roennengart, E
- Amant, F
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0732-183X, 1527-7755
- Tipo:
- Meeting Abstract
- Páginas:
- -
- Factor de Impacto:
- 10,683 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CLINICAL ONCOLOGY LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Mirza,MR,Lundgren,C,Kridelka,F,Ferrero,A,Greggi,S,Christensen,RD,Santaballa,A et al. Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial. 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO). 2017. Chicago. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2017.